Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
:MFY
Holding DE:MFY?
Track your performance easily
MFY Stock Chart & Stats
Day’s Range― - ―
52-Week Range€16.60 - €22.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€707.69M
Enterprise Value€67.09B
Total Cash (Recent Filing)$54.31B
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)25.3
Beta0.41
Next Earnings
Feb 07, 2025EPS EstimateN/A
Next Dividend Ex-Date
Mar 28, 2025Dividend Yield2.48%
Share Statistics
EPS (TTM)0.78
Shares Outstanding37,470,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap94.80
Enterprise Value/Revenue0.83
Enterprise Value/Gross Profit1.13
Enterprise Value/Ebitda6.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mochida Pharmaceutical Co., Ltd. News
PremiumCompany Announcements
Mochida Pharmaceutical Reports Stable Financial Performance
PremiumCompany Announcements
Mochida Pharmaceutical Sees Mixed Q1 Results, Stable OutlookOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.02% Mutual Funds
― Other Institutional Investors
94.80% Public Companies and
Individual Investors
MFY FAQ
What was Mochida Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Mochida Pharmaceutical Co., Ltd. lowest stock price was €16.60 and its highest was €22.40 in the past 12 months.
What is Mochida Pharmaceutical Co., Ltd.’s market cap?
Mochida Pharmaceutical Co., Ltd.’s market cap is €707.69M.
When is Mochida Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Mochida Pharmaceutical Co., Ltd.’s upcoming earnings report date is Feb 07, 2025 which is in 18 days.
How were Mochida Pharmaceutical Co., Ltd.’s earnings last quarter?
Mochida Pharmaceutical Co., Ltd. released its earnings results on Nov 01, 2024. The company reported €0.222 earnings per share for the quarter, beating the consensus estimate of N/A by €0.222.
Is Mochida Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Mochida Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Mochida Pharmaceutical Co., Ltd. pay dividends?
Mochida Pharmaceutical Co., Ltd. does not currently pay dividends.
What is Mochida Pharmaceutical Co., Ltd.’s EPS estimate?
Mochida Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mochida Pharmaceutical Co., Ltd. have?
Mochida Pharmaceutical Co., Ltd. has 37,470,000 shares outstanding.
What happened to Mochida Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Mochida Pharmaceutical Co., Ltd. reported an EPS of €0.222 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of Mochida Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in DE:MFY
---
Company Description
Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
---
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Eisai Co
―
Shionogi & Co
―
---